Storage and handling
Store at room temperature.
Malacetic Ultra Otic Cleanser
- Manufacturer
- Dechra Veterinary Products
- Effective date
- 2024-04-03
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:42:58
Label at a glance#
ProductMalacetic Ultra Otic Cleanser
Active ingredientHydrocortisone, Ketoconazole
Label structure7 sections
Contacts and useful links#
Websitewww.dechra-us.com
www.dechra-us.com
www.dechra-us.comLabel contents#
Full prescribing information#
VETERINARY INDICATIONS SECTION
For ear cleaning and use as a drying agent in dogs, cats and horses with inflamed and infected ears due to bacteria and/or fungi (yeast). Ceramides aid in moisturizing, repairing, and restoring dry, damaged skin.
DESCRIPTION SECTION
Active Ingredients: 1% Hydrocortisone, USP; 0.15% Ketoconazole, USP
Also Contains: Propylene Glycol, SD Alcohol 40-B, Glycerin, Polysorbate 20, Acetic Acid, Ceramide Complex (Ceramide 3, Ceramide 6 II, Ceramide 1, Phytosphingosine, Cholesterol, Sodium Lauroyl Lactylate, Carbomer, Xanthan Gum)
DOSAGE & ADMINISTRATION SECTION
Directions for Use: SHAKE WELL BEFORE EACH USE. Apply to the ear canal and gently, but firmly, massage the base of the ear. Use a cotton ball to remove excess solution. Repeat as necessary or as directed by your veterinarian. Close cap tightly.
WARNINGS SECTION
Caution: For topical use only. Avoid contact with eyes. If skin irritation develops or increases, stop use and call your veterinarian. Keep out of the reach of children and pets. Wash hands after use.
STORAGE AND HANDLING SECTION
Store at room temperature.
SPL UNCLASSIFIED SECTION
Available through licensed veterinarians.
For Veterinary Use Only.
Manufactured for:
Dechra Veterinary Products
7015 College Blvd.
Overland Park, KS 66211
(866) 933-2472
8MUW REV09/23-V
PRINCIPAL DISPLAY PANEL - 236 mL Bottle Label
SHAKE WELL BEFORE USING
MalAcetic ULTRA®
Otic Cleanser
1% Hydrocortisone, USP
0.15% Ketoconazole, USP
Formulated for dogs, cats
and horses
Cleansing, drying,
anti-inflammatory,
antimicrobial, antifungal
8 fl. oz.
(236 mL)
Dechra
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2639745 | hydrocortisone 1 % / ketoconazole 0.15 % Otic Solution | PSN | 4 |
| 2639748 | Malacetic ULTRA 1 % / 0.15 % Otic Solution | PSN | 4 |
| 2639748 | hydrocortisone 10 MG/ML / ketoconazole 1.5 MG/ML Otic Solution [Malacetic] | SBD | 4 |
| 2639745 | hydrocortisone 10 MG/ML / ketoconazole 1.5 MG/ML Otic Solution | SCD | 4 |
| 2639745 | hydrocortisone 1 % / ketoconazole 0.15 % Otic Solution | SY | 4 |
| 2639748 | Malacetic Ultra 1 % / 0.15 % Otic Solution | SY | 4 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| KETOCONAZOLE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17033-142-02 | Malacetic Ultra Otic Cleanser | 59 mL in 1 BOTTLE | LIQUID | 59 | 4 | |
| 17033-142-08 | Malacetic Ultra Otic Cleanser | 236 mL in 1 BOTTLE | LIQUID | 236 | 4 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Malacetic Ultra Otic Cleanser
- Hydrocortisone and Ketoconazole
- Hydrocortisone
- Ketoconazole
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17033-142 | 17033-142-02, 17033-142-08 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Hydrocortisone | WI4X0X7BPJ | ACTIB |
| Ketoconazole | R9400W927I | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.